Adjunctive rosiglitazone treatment for severe paediatric malaria: a randomized placebo-controlled trial in Mozambican children.

In 2021 malaria caused ∼247 million clinical episodes, 2-4 million cases of severe disease and an estimated 619,000 deaths [1]. The highest mortality rates occur in sub-Saharan African children under the age of five.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research